SECOND NEOPLASMS IN DIAGNOSTIC PATIENTS OF POLYCYTHEMIA VERA (PV) OR MIELOFIBROSIS (MF) TREATED WITH RUXOLITINIB

被引：0
|
作者：
Sagues Serrano, M. [1 ]
Osca Gelis, G. [2 ]
Lopez Brunso, M. [3 ]
Gonzalez Montes, Y. [1 ]
Buch Villa, J. [1 ]
Diaz Santa, J. [1 ]
Coll Jorda, R. [1 ]
Cruz Garcia, D. [1 ]
Carvajal Nazly, Santos Y. [1 ]
Lloveras Guelque, N. [1 ]
Kelleher, N. [1 ]
Roncero Vidal, J. M. [1 ]
Blanco Blanco, A. B. [1 ]
Mostacedo Marasovic, S. Z. [1 ]
Bustins Tarrats, A. [1 ]
Serrando Querol, M. [4 ]
Jimenez Romero, O. [4 ]
Tuset Andujar, E. [1 ]
Gallardo Giralt, D. [1 ]
机构：
[1] Hosp Univ Girona Dr Josep Trueta, Serv Hematol, ICO Girona, Girona, Spain
[2] Univ Girona, Fac Ciencies Econ & Empresarials, Hosp Univ Girona Dr Josep Trueta, ICO Girona, Girona, Spain
[3] Hosp Univ Girona Dr Josep Trueta, Serv Farm Hosp, ICO Girona, Girona, Spain
[4] Inst Catala Salut, Lab Clin Area Terr Girona, Girona, Spain
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-196
引用
收藏
页码：310 / 311
页数：2
相关论文
共 50 条
  • [1] Ruxolitinib for the treatment of patients with polycythemia vera
    Kiladjian, Jean-Jacques
    Winton, Elliott F.
    Talpaz, Moshe
    Verstovsek, Srdan
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 391 - 401
  • [2] Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies
    Rohit Sekhri
    Parvis Sadjadian
    Tatjana Becker
    Vera Kolatzki
    Karlo Huenerbein
    Raphael Meixner
    Hannah Marchi
    Rudolf Wallmann
    Christiane Fuchs
    Martin Griesshammer
    Kai Wille
    Annals of Hematology, 2021, 100 : 2707 - 2716
  • [3] Ruxolitinib-treated polycythemia vera patients and their risk of secondary malignancies
    Sekhri, Rohit
    Sadjadian, Parvis
    Becker, Tatjana
    Kolatzki, Vera
    Huenerbein, Karlo
    Meixner, Raphael
    Marchi, Hannah
    Wallmann, Rudolf
    Fuchs, Christiane
    Griesshammer, Martin
    Wille, Kai
    ANNALS OF HEMATOLOGY, 2021, 100 (11) : 2707 - 2716
  • [4] USE OF RUXOLITINIB IN PATIENTS DIAGNOSED WITH POLYCYTHEMIA VERA (PV): EXPERIENCE OF THE CATALAN INSTITUTE OF ONCOLOGY
    Sagues Serrano, M.
    Osca Gelis, G.
    Estrada, N.
    Vallansot, R.
    Boque Genovard, C.
    Lopez Brunso, M.
    Buch Villa, J.
    Diaz Santa, J.
    Fernandez, A.
    Guerra Prio, S.
    Marull Arnall, A.
    Tejerina Fontaina, P.
    Mateu Esquerda, G.
    Moret Puig, C.
    Quinones Roces, M. T.
    Llopis Puigmarti, M. F.
    Zamora Plana, L.
    Xicoy Cirici, B.
    HAEMATOLOGICA, 2019, 104 : 171 - 171
  • [5] COMPLETE HEMATOLOGIC CONTROL WITH RUXOLITINIB IN PATIENTS WITH POLYCYTHEMIA VERA (PV) RESISTANT TO OR INTOLERANT OF HYDROXYUREA
    Harrison, C. N.
    Masszi, T.
    Zachee, P.
    Pane, F.
    Vannucchi, A. M.
    Verstovsek, S.
    Jones, M. M.
    Hunter, D. S.
    He, S.
    Li, J.
    Khan, M.
    Habr, D.
    Kiladjian, J. -J.
    HAEMATOLOGICA, 2015, 100 : 541 - 542
  • [6] RUXOLITINIB PROVIDES CONSISTENT HEMATOCRIT CONTROL IN PATIENTS WITH POLYCYTHEMIA VERA (PV) RESISTANT TO OR INTOLERANT OF HYDROXYUREA
    Griesshammer, M.
    Passamonti, F.
    Durrant, S.
    Kiladjian, J. -J.
    Verstovsek, S.
    Jones, M. M.
    Hunter, D. S.
    He, S.
    Urva, S.
    Li, J.
    Khan, M.
    Habr, D.
    Vannucchi, A. M.
    HAEMATOLOGICA, 2015, 100 : 262 - 263
  • [7] Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice
    Chojecki, Aleksander
    Boselli, Danielle
    Dortilus, Allison
    Hamadeh, Issam
    Begley, Stephanie
    Chen, Tommy
    Bose, Rupali
    Podoltsev, Nikolai
    Zeidan, Amer M.
    Balmaceda, Nicole Baranda
    Yacoub, Abdulraheem
    Ai, Jing
    Knight, Thomas Gregory
    Ragon, Brittany Knick
    Shah, Nilay Arvind
    Sanikommu, Srinivasa Reddy
    Symanowski, James
    Mesa, Ruben
    Grunwald, Michael Richard
    ANNALS OF HEMATOLOGY, 2024, 103 (08) : 2837 - 2843
  • [8] Ruxolitinib in patients with polycythemia vera with hydroxyurea resistance or intolerance
    Venugopal, Sangeetha
    Mascarenhas, John
    LANCET HAEMATOLOGY, 2022, 9 (07): : E462 - E463
  • [9] Identification for and Management of Patients with PV and MF with Ruxolitinib
    Guerra, Veronica A.
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S10 - S11
  • [10] Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera?
    Beauverd, Yan
    McLornan, Donal P.
    Radia, Deepti H.
    Harrison, Claire N.
    FUTURE ONCOLOGY, 2016, 12 (06) : 739 - 749
12345